Oxford Asset Management’s Pfizer PFE Stock Holding History

Oxford Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-96,156	Closed	-$2.45M	–	689
2025 Q3	$2.45M	Buy	+96,156	New	+$2.37M	0.81%	12
2025 Q2	–	Sell	-52,570	Closed	-$1.33M	–	709
2025 Q1	$1.33M	Buy	52,570 +25,090	+91%	+$657K	0.61%	29
2024 Q4	$729K	Buy	+27,480	New	+$745K	0.32%	86
2018 Q4	–	Sell	-128,932	Closed	-$5.38M	–	2006
2018 Q3	$5.38M	Buy	+128,932	New	+$4.96M	0.11%	207
2018 Q1	–	Sell	-332,669	Closed	-$11.5M	–	1828
2017 Q4	$11.5M	Sell	332,669 -10,681	-3%	-$364K	0.25%	47
2017 Q3	$11.6M	Sell	343,350 -115,898	-25%	-$3.72M	0.22%	52
2017 Q2	$14.6M	Buy	+459,248	New	+$14.5M	0.29%	34

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Oxford Asset Management's PFE Position: Q4 2025 in Review

Oxford Asset Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 96,156 shares — an estimated $2.45M sold.

Oxford Asset Management first reported a position in PFE in Q2 2017 and held it in 7 quarters. The position peaked at $14.6M in Q2 2017. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Oxford Asset Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Oxford Asset Management sold 96,156 Pfizer shares in Q4 2025, an estimated $2.45M.
Oxford Asset Management first reported a position in Pfizer in Q2 2017 and held it in 7 quarters.
Oxford Asset Management's Pfizer position peaked at $14.6M in Q2 2017.
2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.